pioglitazone has been researched along with Hepatopulmonary Syndrome in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Hepatopulmonary Syndrome: A syndrome characterized by the clinical triad of advanced chronic liver disease, pulmonary vascular dilatations, and reduced arterial oxygenation (HYPOXEMIA) in the absence of intrinsic cardiopulmonary disease. This syndrome is common in the patients with LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsai, HC | 1 |
| Yang, YY | 1 |
| Cheng, TY | 1 |
| Lee, WS | 1 |
| Huang, HC | 1 |
| Lee, FY | 1 |
| Chang, CC | 1 |
| Lin, HC | 1 |
| Lee, SD | 1 |
2 other studies available for pioglitazone and Hepatopulmonary Syndrome
| Article | Year |
|---|---|
Pioglitazone decrease intrapulmonary shunt in biliary cirrhotic rats with hepatopulmonary syndrome.
Topics: Animals; Hepatopulmonary Syndrome; Liver Cirrhosis; Pioglitazone; Rats; Thiazolidinediones | 2017 |
The effects of pioglitazone in cirrhotic rats with hepatopulmonary syndrome.
Topics: Angiogenesis Inhibitors; Animals; Endothelin-1; Hepatopulmonary Syndrome; Liver Cirrhosis; Male; Nit | 2017 |